[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Rabies Vaccine for Humans Market Status and Outlook 2018-2025

August 2018 | 146 pages | ID: G5B26F1C9BDEN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies
  • Novartis
  • Sanofi
  • GlaxoSmithKline
  • Merck
  • Chengda
  • Yisheng
  • Prcmise
  • VACN
  • Changsheng
  • BCHT
  • Hissen
Market by Type
  • Preventative Vaccine
  • Emergency Rabies Vaccine
Market by Application
  • Pre-exposure prophylaxis
  • Post-exposure prophylaxis
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Rabies Vaccine for Humans Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Preventative Vaccine
  3.1.2 Emergency Rabies Vaccine
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Pre-exposure prophylaxis
  4.1.2 Post-exposure prophylaxis
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Preventative Vaccine Production by Region
    6.1.1.2 Emergency Rabies Vaccine Production by Region
  6.1.2 Production by Application
    6.1.2.1 Pre-exposure prophylaxis Production by Region
    6.1.2.2 Post-exposure prophylaxis Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Preventative Vaccine Demand by Region
    6.2.1.2 Emergency Rabies Vaccine Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Pre-exposure prophylaxis Demand by Region
    6.2.2.2 Post-exposure prophylaxis Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Novartis
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Sanofi
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 GlaxoSmithKline
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Merck
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Chengda
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Yisheng
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Prcmise
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 VACN
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Changsheng
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 BCHT
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Hissen

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Rabies Vaccine for Humans Industry Dynamics & Regulations List
Table Global Rabies Vaccine for Humans Sales Revenue, Cost and Margin, 2015-2018E
Table Global Rabies Vaccine for Humans Market Status by Type 2015-2018E, in USD Million
Table Global Rabies Vaccine for Humans Market Status by Application 2015-2018E, in USD Million
Table Global Rabies Vaccine for Humans Market Status by Application 2015-2018E, in Volume
Table Global Rabies Vaccine for Humans Market by Region 2015-2018E, in USD Million
Table Global Rabies Vaccine for Humans Market Share by Region in 2018, in USD Million
Table Global Rabies Vaccine for Humans Market by Region 2015-2018E, in Volume
Table Global Rabies Vaccine for Humans Market Share by Region in 2018, in Volume
Table Preventative Vaccine Production Value by Region 2015-2018E, in USD Million
Table Preventative Vaccine Production Volume by Region 2015-2018E, in Volume
Table Emergency Rabies Vaccine Production Value by Region 2015-2018E, in USD Million
Table Emergency Rabies Vaccine Production Volume by Region 2015-2018E, in Volume
Table Pre-exposure prophylaxis Production Value by Region 2015-2018E, in USD Million
Table Pre-exposure prophylaxis Production Volume by Region 2015-2018E, in Volume
Table Post-exposure prophylaxis Production Value by Region 2015-2018E, in USD Million
Table Post-exposure prophylaxis Production Volume by Region 2015-2018E, in Volume
Table Preventative Vaccine Market Size by Region 2015-2018E, in USD Million
Table Preventative Vaccine Market Size by Region 2015-2018E, in Volume
Table Emergency Rabies Vaccine Market Size by Region 2015-2018E, in USD Million
Table Emergency Rabies Vaccine Market Size by Region 2015-2018E, in Volume
Table Pre-exposure prophylaxis Market Size by Region 2015-2018E, in USD Million
Table Pre-exposure prophylaxis Market Size by Region 2015-2018E, in Volume
Table Post-exposure prophylaxis Market Size by Region 2015-2018E, in USD Million
Table Post-exposure prophylaxis Market Size by Region 2015-2018E, in Volume
Table GlobalRabies Vaccine for Humans Forecast by Type 2019F-2025F, in USD Million
Table Rabies Vaccine for Humans Forecast by Type 2019F-2025F, in Volume
Table Rabies Vaccine for Humans Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Rabies Vaccine for Humans Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Rabies Vaccine for Humans Market Forecast by Region 2019F-2025F, in USD Million
Table Rabies Vaccine for Humans Market Forecast by Region 2019F-2025F, in Volume
Table Novartis Information
Table Rabies Vaccine for Humans Sales, Cost, Margin of Novartis
Table Sanofi Information
Table Rabies Vaccine for Humans Sales, Cost, Margin of Sanofi
Table GlaxoSmithKline Information
Table Rabies Vaccine for Humans Sales, Cost, Margin of GlaxoSmithKline
Table Merck Information
Table Rabies Vaccine for Humans Sales, Cost, Margin of Merck
Table Chengda Information
Table Rabies Vaccine for Humans Sales, Cost, Margin of Chengda
Table Yisheng Information
Table Rabies Vaccine for Humans Sales, Cost, Margin of Yisheng
Table Prcmise Information
Table Rabies Vaccine for Humans Sales, Cost, Margin of Prcmise
Table VACN Information
Table Rabies Vaccine for Humans Sales, Cost, Margin of VACN
Table Changsheng Information
Table Rabies Vaccine for Humans Sales, Cost, Margin of Changsheng
Table BCHT Information
Table Rabies Vaccine for Humans Sales, Cost, Margin of BCHT
Table Hissen Information
Table Rabies Vaccine for Humans Sales, Cost, Margin of Hissen
Table Global Rabies Vaccine for Humans Sales Revenue by Company 2015-2017, in USD Million
Table Global Rabies Vaccine for Humans Sales Volume by Company 2015-2017, in Volume
Table Global Rabies Vaccine for Humans Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Rabies Vaccine for Humans Picture
Figure Rabies Vaccine for Humans Industry Chain Diagram
Figure Global Rabies Vaccine for Humans Sales Revenue 2015-2018E, in USD Million
Figure Global Rabies Vaccine for Humans Sales Volume 2015-2018E, in Volume
Figure Global Rabies Vaccine for Humans Market Status by Type 2015-2018E, in Volume
Figure North America Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in USD Million
Figure North America Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in Volume
Figure Europe Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in USD Million
Figure Europe Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in Volume
Figure South America Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in USD Million
Figure South America Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in Volume
Figure Middle East Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in Volume
Figure Africa Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in USD Million
Figure Africa Rabies Vaccine for Humans Market Size and Growth 2015-2018E, in Volume
Figure Global Rabies Vaccine for Humans Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Rabies Vaccine for Humans Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Rabies Vaccine for Humans Sales Price Forecast 2019F-2025F
Figure Global Rabies Vaccine for Humans Gross Margin Forecast 2019F-2025F
Figure Global Rabies Vaccine for Humans Sales Revenue by Company in 2018, in USD Million
Figure Global Rabies Vaccine for Humans Price by Company in 2018
Figure Global Rabies Vaccine for Humans Gross Margin by Company in 2018


More Publications